DK107391D0 - Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen - Google Patents

Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen

Info

Publication number
DK107391D0
DK107391D0 DK911073A DK107391A DK107391D0 DK 107391 D0 DK107391 D0 DK 107391D0 DK 911073 A DK911073 A DK 911073A DK 107391 A DK107391 A DK 107391A DK 107391 D0 DK107391 D0 DK 107391D0
Authority
DK
Denmark
Prior art keywords
pct
cells
isolation
maternal blood
fetal cells
Prior art date
Application number
DK911073A
Other languages
English (en)
Other versions
DK107391A (da
Inventor
Utz Walter Mueller
Catherine Stella Hawes
Original Assignee
Flinders Technologies Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flinders Technologies Pty Ltd filed Critical Flinders Technologies Pty Ltd
Publication of DK107391D0 publication Critical patent/DK107391D0/da
Publication of DK107391A publication Critical patent/DK107391A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK107391A 1988-12-06 1991-06-06 Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen DK107391A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ182488 1988-12-06
PCT/AU1989/000517 WO1990006509A1 (en) 1988-12-06 1989-11-29 Isolation of fetal cells from maternal blood to enable prenatal diagnosis

Publications (2)

Publication Number Publication Date
DK107391D0 true DK107391D0 (da) 1991-06-06
DK107391A DK107391A (da) 1991-07-31

Family

ID=3773565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK107391A DK107391A (da) 1988-12-06 1991-06-06 Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen

Country Status (11)

Country Link
US (1) US5503981A (da)
EP (1) EP0447424B1 (da)
JP (1) JP2935741B2 (da)
CN (1) CN1021257C (da)
AT (1) ATE161960T1 (da)
CA (1) CA2004592A1 (da)
DE (1) DE68928535T2 (da)
DK (1) DK107391A (da)
ES (1) ES2112833T3 (da)
NZ (1) NZ231621A (da)
WO (1) WO1990006509A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475720B1 (en) 1986-01-16 2002-11-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
US5756696A (en) * 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US7115709B1 (en) * 1986-01-16 2006-10-03 The Regents Of The University Of California Methods of staining target chromosomal DNA employing high complexity nucleic acid probes
US6872817B1 (en) 1986-01-16 2005-03-29 The Regents Of The Univ. Of California Method of staining target interphase chromosomal DNA
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US6344315B1 (en) 1986-01-16 2002-02-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
ES2113344T3 (es) * 1989-08-03 1998-05-01 Univ California Metodo para aislar celulas de citotrofoblastos fetales.
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
ATE162631T1 (de) * 1989-11-13 1998-02-15 Childrens Medical Center Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
US5153117A (en) * 1990-03-27 1992-10-06 Genetype A.G. Fetal cell recovery method
FR2682481A1 (fr) * 1991-10-11 1993-04-16 Saint Cy Scp Procede d'obtention de cellules trophoblastiques d'un fóoetus.
CA2122138A1 (en) * 1991-10-23 1993-04-29 Sheryl Williams A method for enriching fetal progenitor cells from maternal blood
FR2685777A1 (fr) * 1991-12-31 1993-07-02 Bertin & Cie Procede de depistage prenatal d'anomalies fóoetales et procede de depistage prenatal du sexe.
DE4222573C1 (da) * 1992-05-16 1993-08-12 Dorothee Dr. 4400 Muenster De Ahlert
US5457024A (en) * 1993-01-22 1995-10-10 Aprogenex, Inc. Isolation of fetal erythrocytes
US5662813A (en) * 1994-10-21 1997-09-02 Bioseparations, Inc. Method for separation of nucleated fetal erythrocytes from maternal blood samples
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5801145A (en) * 1996-02-09 1998-09-01 Ontario Cancer Institute Method for selectively purging CD77+ cells from bone marrow
AUPO931997A0 (en) * 1997-09-22 1997-10-09 Flinders Technologies Pty Ltd Enrichment and identification of trophoblast cells in maternal peripheral blood
US6221596B1 (en) 1999-05-17 2001-04-24 Motobit Ltd. System and method for identifying and isolating rare cells from a mixed population of cells
AU5967100A (en) * 1999-07-21 2001-02-13 Britta Christensen A novel method for the improved isolation of a target cell population
DE19964044C2 (de) * 1999-12-30 2001-11-22 Frank Hans Georg Verfahren zur Identifizierung von Substanzen, die Säugetier-Epitope nachahmen
IL150216A0 (en) * 1999-12-30 2002-12-01 Hans Georg Frank Method for identifying substances which mimic mammal epitopes
US20020045196A1 (en) * 2000-05-12 2002-04-18 Walt Mahoney Methods of isolating trophoblast cells from maternal blood
US20050100951A1 (en) * 2000-10-26 2005-05-12 Biocept, Inc. 3D format biochips and method of use
FR2824144B1 (fr) * 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
NZ537328A (en) * 2002-05-31 2008-04-30 Genetic Technologies Ltd Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
CA2500392C (en) 2002-09-27 2012-11-27 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8394582B2 (en) * 2003-03-05 2013-03-12 Genetic Technologies, Inc Identification of fetal DNA and fetal cell markers in maternal plasma or serum
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20040197832A1 (en) * 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
WO2005035725A2 (en) * 2003-10-08 2005-04-21 The Trustees Of Boston University Methods for prenatal diagnosis of chromosomal abnormalities
US7439062B2 (en) * 2004-12-23 2008-10-21 Biocept, Inc. Beads for capturing target cells from bodily fluid
FR2880897B1 (fr) 2005-01-18 2010-12-17 Inst Nat Sante Rech Med Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
EP2152905B1 (en) * 2007-05-01 2015-12-02 Tel Hashomer Medical Research Infrastructure and Services Ltd. Methods and kits for detecting fetal cells in the maternal blood
WO2009103110A1 (en) * 2008-02-18 2009-08-27 Genetic Technologies Limited Cell processing and/or enrichment methods
EP3751005A3 (en) 2008-09-20 2021-02-24 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9447467B2 (en) 2009-04-21 2016-09-20 Genetic Technologies Limited Methods for obtaining fetal genetic material
CA2765779A1 (en) * 2009-06-24 2010-12-29 Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
CN101935700A (zh) * 2010-07-15 2011-01-05 浙江大学 鉴定绵羊早期胚胎性别的牙釉蛋白基因引物及其应用
US10058306B2 (en) 2012-06-22 2018-08-28 Preprogen, LLC Method for obtaining fetal cells and fetal cellular components
CN103230416A (zh) * 2013-04-16 2013-08-07 中国人民解放军第三军医大学第三附属医院 一种小鼠合体滋养细胞微绒毛膜的制备方法及其应用
US10330680B2 (en) * 2014-10-10 2019-06-25 Wayne State University Methods of assaying RNA from fetal extravillous trophoblast cells isolated from a maternal endocervical sample
RU2695356C1 (ru) * 2018-11-14 2019-07-23 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ прогнозирования состояния плода при преждевременном разрыве плодных оболочек с 24 до 33 недель беременности
CN112980779B (zh) * 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining

Also Published As

Publication number Publication date
EP0447424A1 (en) 1991-09-25
DE68928535T2 (de) 1998-04-16
EP0447424A4 (en) 1992-06-24
DE68928535D1 (de) 1998-02-12
NZ231621A (en) 1992-11-25
CN1043788A (zh) 1990-07-11
JP2935741B2 (ja) 1999-08-16
ATE161960T1 (de) 1998-01-15
DK107391A (da) 1991-07-31
CA2004592A1 (en) 1990-06-06
ES2112833T3 (es) 1998-04-16
CN1021257C (zh) 1993-06-16
WO1990006509A1 (en) 1990-06-14
EP0447424B1 (en) 1998-01-07
JPH04502060A (ja) 1992-04-09
US5503981A (en) 1996-04-02

Similar Documents

Publication Publication Date Title
DK107391A (da) Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen
Anai et al. Vaginal fluid hCG levels for detecting premature rupture of membranes
Boué et al. Cases of human infertility are associated with the absence of P34H, an epididymal sperm antigen
Westergaard et al. Pregnancy-associated plasma protein A in the prediction of early pregnancy failure
Gamzu et al. The hemizona assay is of good prognostic value for the ability of sperm to fertilize oocytes in vitro
Bajoria et al. Atrial natriuretic peptide mediated polyuria: pathogenesis of polyhydramnios in the recipient twin of twin-twin transfusion syndrome
Mulivor et al. Origin of the alkaline phosphatases in amniotic fluid
Rubinstein et al. HLA antigens and islet cell antibodies in gestational diabetes
EP0731915A1 (en) Prenatal detection of meconium
Sasagawa et al. Immunohistochemical localization of HLA antigens and placental proteins (αhCG, βhCG CTP, hPL and SP1 in villous and extravillous trophoblast in normal human pregnancy: a distinctive pathway of differentiation of extravillous trophoblast
Lin et al. Relation of obstetric parameters to the concentrations of four pregnancy-associated plasma proteins at term in normal gestation
White et al. Immunofluorescent detection of a male-specific factor on preimplantation bovine embryos
Zigril et al. Immunopotentiation reverses the embryotoxic effect of serum from women with pregnancy loss
Wald et al. First trimester biochemical screening for Down's syndrome
Bersinger et al. Pregancy-specific and pregnancy-associated proteins in threatened abortion
Jauniaux et al. Coelomic fluid chorionic gonadotrophin and protein concentrations in normal and complicated first trimester human pregnancies
Rosen et al. PLACENTAL ISOFERRITIN IN PREGNANCIES WITH SMALL‐FOR‐GESTATIONAL‐AGE FETUSES
Shimizu et al. Prenatal diagnosis of epidermolysis bullosa: first successful trial in Asia
Horn et al. Prenatal diagnosis of Menkes’ syndrome by direct copper analysis of trophoblastic tissue
Smith et al. Progesterone concentrations in the peripheral plasma of pregnant ewes following infection with an abortifacient organism
Gimsing et al. Vitamin B12 binding proteins in amniotic fluid
Shahani et al. Early pregnancy factor (EPF) as a marker for the diagnosis of subclinical embryonic loss
Bock et al. Alpha-fetoprotein in amniotic fluid and serum from pregnant women with severe rhesus isoimmunization
Fisch et al. Placental isoferritin as a marker of early abortion in pregnancies induced by in vitro fertilization
Obiekwe et al. Placental protein 5: circulating levels in twin pregnancy and some observations on the analysis of biochemical data from multiple pregnancy